BRIGHTSPRING HEALTH SERVICES (BTSG) Fundamental Analysis & Valuation

NASDAQ:BTSG • US10950A1060

Current stock price

52.58 USD
+4.61 (+9.61%)
At close:
52.0142 USD
-0.57 (-1.08%)
After Hours:

This BTSG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BTSG Profitability Analysis

1.1 Basic Checks

  • In the past year BTSG was profitable.
  • BTSG had a positive operating cash flow in the past year.
  • In multiple years BTSG reported negative net income over the last 5 years.
  • BTSG had a positive operating cash flow in 4 of the past 5 years.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • The Return On Assets of BTSG (2.97%) is better than 63.00% of its industry peers.
  • With a decent Return On Equity value of 10.17%, BTSG is doing good in the industry, outperforming 71.00% of the companies in the same industry.
  • BTSG has a Return On Invested Capital of 4.92%. This is comparable to the rest of the industry: BTSG outperforms 55.00% of its industry peers.
  • BTSG had an Average Return On Invested Capital over the past 3 years of 3.12%. This is significantly below the industry average of 8.40%.
  • The last Return On Invested Capital (4.92%) for BTSG is above the 3 year average (3.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.97%
ROE 10.17%
ROIC 4.92%
ROA(3y)-0.04%
ROA(5y)-0.04%
ROE(3y)-5.79%
ROE(5y)-3.62%
ROIC(3y)3.12%
ROIC(5y)3.41%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • BTSG has a Profit Margin (1.48%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of BTSG has grown nicely.
  • With a Operating Margin value of 2.29%, BTSG perfoms like the industry average, outperforming 49.00% of the companies in the same industry.
  • BTSG's Operating Margin has declined in the last couple of years.
  • The Gross Margin of BTSG (11.76%) is worse than 69.00% of its industry peers.
  • In the last couple of years the Gross Margin of BTSG has declined.
Industry RankSector Rank
OM 2.29%
PM (TTM) 1.48%
GM 11.76%
OM growth 3Y-8.26%
OM growth 5Y-5.03%
PM growth 3YN/A
PM growth 5Y31.69%
GM growth 3Y-12.49%
GM growth 5Y-8.96%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BTSG Health Analysis

2.1 Basic Checks

  • BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BTSG has more shares outstanding
  • Compared to 5 years ago, BTSG has more shares outstanding
  • BTSG has a better debt/assets ratio than last year.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BTSG has an Altman-Z score of 3.57. This indicates that BTSG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.57, BTSG is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
  • The Debt to FCF ratio of BTSG is 6.41, which is on the high side as it means it would take BTSG, 6.41 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 6.41, BTSG perfoms like the industry average, outperforming 49.00% of the companies in the same industry.
  • BTSG has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.32, BTSG is doing worse than 68.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.41
Altman-Z 3.57
ROIC/WACC0.55
WACC8.91%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • BTSG has a Current Ratio of 1.57. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.57, BTSG is doing good in the industry, outperforming 61.00% of the companies in the same industry.
  • A Quick Ratio of 1.12 indicates that BTSG should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.12, BTSG perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.12
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. BTSG Growth Analysis

3.1 Past

  • BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.45%, which is quite impressive.
  • Measured over the past years, BTSG shows a very strong growth in Earnings Per Share. The EPS has been growing by 48.27% on average per year.
  • The Revenue has grown by 14.59% in the past year. This is quite good.
  • Measured over the past years, BTSG shows a quite strong growth in Revenue. The Revenue has been growing by 18.27% on average per year.
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5Y48.27%
EPS Q2Q%50%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y18.69%
Revenue growth 5Y18.27%
Sales Q2Q%16.31%

3.2 Future

  • Based on estimates for the next years, BTSG will show a very strong growth in Earnings Per Share. The EPS will grow by 36.60% on average per year.
  • BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.09% yearly.
EPS Next Y40.58%
EPS Next 2Y33.04%
EPS Next 3Y32.81%
EPS Next 5Y36.6%
Revenue Next Year16.56%
Revenue Next 2Y14.54%
Revenue Next 3Y14.71%
Revenue Next 5Y17.09%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. BTSG Valuation Analysis

4.1 Price/Earnings Ratio

  • BTSG is valuated quite expensively with a Price/Earnings ratio of 46.53.
  • The rest of the industry has a similar Price/Earnings ratio as BTSG.
  • When comparing the Price/Earnings ratio of BTSG to the average of the S&P500 Index (26.64), we can say BTSG is valued expensively.
  • The Price/Forward Earnings ratio is 33.10, which means the current valuation is very expensive for BTSG.
  • BTSG's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. BTSG is valued rather expensively when compared to this.
Industry RankSector Rank
PE 46.53
Fwd PE 33.1
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • BTSG's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.73
EV/EBITDA 25.47
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BTSG's earnings are expected to grow with 32.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.15
PEG (5Y)0.96
EPS Next 2Y33.04%
EPS Next 3Y32.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BTSG Dividend Analysis

5.1 Amount

  • BTSG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BTSG Fundamentals: All Metrics, Ratios and Statistics

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (5/1/2026, 8:12:52 PM)

After market: 52.0142 -0.57 (-1.08%)

52.58

+4.61 (+9.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)05-01
Earnings (Next)07-30
Inst Owners78.51%
Inst Owner Change-0.05%
Ins Owners2.5%
Ins Owner Change7.38%
Market Cap10.16B
Revenue(TTM)12.91B
Net Income(TTM)190.67M
Analysts86.36
Price Target53.31 (1.39%)
Short Float %7.34%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.02%
Min EPS beat(2)-7.56%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)39.33%
Min EPS beat(4)-7.56%
Max EPS beat(4)97.01%
EPS beat(8)4
Avg EPS beat(8)19.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.22%
Revenue beat(4)4
Avg Revenue beat(4)3.06%
Min Revenue beat(4)2.86%
Max Revenue beat(4)3.24%
Revenue beat(8)7
Avg Revenue beat(8)3.51%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.29%
PT rev (3m)27.26%
EPS NQ rev (1m)2.28%
EPS NQ rev (3m)21.57%
EPS NY rev (1m)14.55%
EPS NY rev (3m)16.19%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)2.37%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 46.53
Fwd PE 33.1
P/S 0.79
P/FCF 25.73
P/OCF 20.72
P/B 5.42
P/tB N/A
EV/EBITDA 25.47
EPS(TTM)1.13
EY2.15%
EPS(NY)1.59
Fwd EY3.02%
FCF(TTM)2.04
FCFY3.89%
OCF(TTM)2.54
OCFY4.83%
SpS66.84
BVpS9.71
TBVpS-6.36
PEG (NY)1.15
PEG (5Y)0.96
Graham Number15.7097 (-70.12%)
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 10.17%
ROCE 6.47%
ROIC 4.92%
ROICexc 5.01%
ROICexgc 16.35%
OM 2.29%
PM (TTM) 1.48%
GM 11.76%
FCFM 3.06%
ROA(3y)-0.04%
ROA(5y)-0.04%
ROE(3y)-5.79%
ROE(5y)-3.62%
ROIC(3y)3.12%
ROIC(5y)3.41%
ROICexc(3y)3.16%
ROICexc(5y)3.45%
ROICexgc(3y)13.08%
ROICexgc(5y)15.96%
ROCE(3y)4.1%
ROCE(5y)4.49%
ROICexgc growth 3Y-3.92%
ROICexgc growth 5Y0.08%
ROICexc growth 3Y9.04%
ROICexc growth 5Y7.15%
OM growth 3Y-8.26%
OM growth 5Y-5.03%
PM growth 3YN/A
PM growth 5Y31.69%
GM growth 3Y-12.49%
GM growth 5Y-8.96%
F-Score8
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.41
Debt/EBITDA 5.37
Cap/Depr 58.12%
Cap/Sales 0.74%
Interest Coverage 1.61
Cash Conversion 106.64%
Profit Quality 207%
Current Ratio 1.57
Quick Ratio 1.12
Altman-Z 3.57
F-Score8
WACC8.91%
ROIC/WACC0.55
Cap/Depr(3y)44.68%
Cap/Depr(5y)39.63%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5Y48.27%
EPS Q2Q%50%
EPS Next Y40.58%
EPS Next 2Y33.04%
EPS Next 3Y32.81%
EPS Next 5Y36.6%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y18.69%
Revenue growth 5Y18.27%
Sales Q2Q%16.31%
Revenue Next Year16.56%
Revenue Next 2Y14.54%
Revenue Next 3Y14.71%
Revenue Next 5Y17.09%
EBIT growth 1Y43.11%
EBIT growth 3Y8.89%
EBIT growth 5Y12.32%
EBIT Next Year78.45%
EBIT Next 3Y34.55%
EBIT Next 5Y30.24%
FCF growth 1Y790.75%
FCF growth 3YN/A
FCF growth 5Y18.25%
OCF growth 1Y1961.79%
OCF growth 3YN/A
OCF growth 5Y17.1%

BRIGHTSPRING HEALTH SERVICES / BTSG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a fundamental rating of 4 / 10 to BTSG.


Can you provide the valuation status for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a valuation rating of 3 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Overvalued.


Can you provide the profitability details for BRIGHTSPRING HEALTH SERVICES?

BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.


What is the expected EPS growth for BRIGHTSPRING HEALTH SERVICES (BTSG) stock?

The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 40.58% in the next year.